Shareholding disclosure

Vincent MUTEL

Declared position

2.79%

Threshold

Crossed upwards

Timeline

Published

22.09.2010

Transaction

16.09.2010

Voting rights breakdown

Voting rights acquired2.79%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAA9L00042

Beneficial owner

Vincent MUTEL

Declared address

Vincent MUTEL, 1180 ROLLE

Franchissement du seuil de 3% de participation à la baisse, suite à augmentation de capital.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Vincent MUTEL

Addex Therapeutics Ltd22.09.2010TAA9L00042

Disclosure summary

Vincent MUTEL disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 22.09.2010, at 2.79% of voting rights. Notice category: Single shareholder.

Disclosed position

2.79%

Voting rights acquired

Voting rights acquired2.79%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Vincent MUTEL disclosed a holding in Addex Therapeutics Ltd, published on 22.09.2010.

Publication date22.09.2010

Transaction date16.09.2010

Issuing companyAddex Therapeutics Ltd

Beneficial ownerVincent MUTEL

Declared addressVincent MUTEL, 1180 ROLLE

CategorySingle shareholder

Voting rights acquired2.79%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAA9L00042

Conditions

Franchissement du seuil de 3% de participation à la baisse, suite à augmentation de capital.

Source: SIX Exchange Regulation · Publication date: 22.09.2010

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open